Vertex Pharmaceuticals Inc. closed 9.68% short of its 52-week high of $519.88, which the company reached on November 8th.

Vertex (VRTX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Vertex Pharmaceuticals (VRTX) reached $464.2 at the closing of the latest trading day, reflecting a -1.73% change compared to its last close.

The US has built three reactors in the past 30 years, but now Westinghouse says it will stand up 10 in partnership with ...

Health care stocks have outperformed so far in 2025 despite uncertainty surrounding the Donald Trump administration's policies. Health care stocks can often be a solid defensive play in an ...

“As the only fully licensed, construction-ready modular reactor available today, our AP1000 technology is the quickest way to add new sources of affordable and abundant nuclear energy to the U.S. grid ...

NHS patients in England with cystic fibrosis will be among the first in Europe to access a new treatment for their condition, ...

Westinghouse Electric Company and Google Cloud have announced collaboration agreement that will deploy artificial ...

Enterprises rushing to embrace generative AI face soaring costs and unclear ROI, often due to poor planning and weak cost ...

While AI systems are known to spew wrong information and make up facts, Google and Westinghouse Electric are now pressing generative AI models into service to transform how nuclear reactors are ...

Westinghouse has announced it is to collaborate with Google Cloud to use artificial intelligence tools to streamline ...

States representing about 84% of Medicaid beneficiaries are participating in an initiative that enables the U.S. government ...